# Willow Life Sciences, Inc. — Form D

Willow Life Sciences, Inc. of ALLSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-06. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2025-11-06
- Form: D
- Accession: 0002083161-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 19
- Date of first sale: 2025-05-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-563278

## Issuer

- Name: Willow Life Sciences, Inc.
- CIK: 0002083161
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 127 WESTERN AVENUE, ALLSTON, MA, 02134
- Phone: (765) 212-9972

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Mariia Grebenshchikova | Director | Allston, MA |
| Morgan Moncada | Director | Allston, MA |
| Catherine Tadina | Director | Allston, MA |
| Morgan Moncada | Executive Officer | Allston, MA |

## More

- [CIK 2083161 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2083161&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002083161-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.